Recent Insider Activity Suggests Potential Gains for Amneal Pharmaceuticals Inc (AMRX)

CHWY Stock

Amneal Pharmaceuticals Inc’s recent filing unveils that its Director Patel Gautam unloaded Company’s shares for reported $0.76 million on Jun 16 ’25. In the deal valued at $8.02 per share,94,906 shares were sold. As a result of this transaction, Patel Gautam now holds 1,609,144 shares worth roughly $13.02 million.

Then, Patel Gautam sold 56,426 shares, generating $452,537 in total proceeds. Upon selling the shares at $8.02, the Director now owns 1,704,050 shares.

Before that, Shah Nikita sold 49,140 shares. Amneal Pharmaceuticals Inc shares valued at $372,481 were divested by the Executive Vice President at a price of $7.58 per share. As a result of the transaction, Shah Nikita now holds 388,929 shares, worth roughly $3.15 million.

Goldman initiated its Amneal Pharmaceuticals Inc [AMRX] rating to a Buy in a research note published on June 06, 2025; the price target was $12. A number of analysts have revised their coverage, including JP Morgan’s analysts, who increased its forecast for the stock in late February from “a Neutral” to “an Overweight”. JP Morgan also remained covering AMRX and has increased its forecast on September 06, 2024 with a “Neutral” recommendation from previously “an Underweight” rating.

Price Performance Review of AMRX

On Monday, Amneal Pharmaceuticals Inc [NASDAQ:AMRX] saw its stock fall -0.49% to $8.09. Over the last five days, the stock has gained 2.21%. Amneal Pharmaceuticals Inc shares have risen nearly 25.04% since the year began. Nevertheless, the stocks have risen 2.15% over the past one year. While a 52-week high of $9.48 was reached on 03/03/25, a 52-week low of $6.29 was recorded on 04/10/25.

Levels Of Support And Resistance For AMRX Stock

The 24-hour chart illustrates a support level at 8.04, which if violated will result in even more drops to 7.98. On the upside, there is a resistance level at 8.18. A further resistance level may holdings at 8.26.

How much short interest is there in Amneal Pharmaceuticals Inc?

A steep rise in short interest was recorded in Amneal Pharmaceuticals Inc stocks on 2025-06-13, dropping by 9576.0 shares to a total of 5.35 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 5.36 million shares. There was a decline of -0.18%, which implies that there is a negative sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.